| PERIOD ENDING | 25-Oct-09 | 26-Jul-09 | 26-Apr-09 | 25-Jan-09 | | Total Revenue | 1,526,394 | 1,133,740 | 1,020,077 | 1,333,396 | | Cost of Revenue | 967,558 | 808,866 | 864,558 | 941,820 | | | Gross Profit | 558,836 | 324,874 | 155,519 | 391,576 | | | Operating Expenses | | Research Development | 234,188 | 234,052 | 236,335 | 229,540 | | Selling General and Administrative | 155,399 | 168,005 | 185,758 | 225,356 | | Non Recurring | 80,787 |
-
| 26,709 | 132,772 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 172,942 | (77,183) | (293,283) | (196,092) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 125,728 | (104,172) | 27,597 | (573) | | Earnings Before Interest And Taxes | 179,207 | (69,291) | (377,750) | (196,665) | | Interest Expense | 5,359 | 4,893 | 5,058 | 5,994 | | Income Before Tax | 173,848 | (74,184) | (382,808) | (202,659) | | Income Tax Expense | 35,986 | (19,319) | (127,418) | (69,725) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 102,879 | (54,865) | (255,390) | (132,934) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 137,862 | (54,865) | (255,390) | (132,934) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $137,862 | ($54,865) | ($255,390) | ($132,934) |
|
0.02% Nasdaq 
Income Statement
